Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Molecular Underpinnings of Skin Regeneration and Wound Healing: The Role of Renin Angiotensin. | Avicenna J Med Biotechnol | 2024 | 39132629 | PubTator, text mining | PubMed |
| Structural and Biochemical Characterization of a New Phage-Encoded Muramidase, KTN6 Gp46. | Phage (New Rochelle) | 2024 | 39119210 | PubTator, text mining | PubMed |
| Photothermal driven BMSCs osteogenesis and M2 macrophage polarization on polydopamine-coated Ti3C2 nanosheets/poly(vinylidene fluoride trifluoroethylene) nanocomposite coatings. | Mater Today Bio | 2024 | 39081463 | PubTator, text mining | PubMed |
| Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta. | J Mol Diagn | 2024 | 39025364 | PubTator, text mining | PubMed |
| Hsp47 promotes biogenesis of multi-subunit neuroreceptors in the endoplasmic reticulum. | Elife | 2024 | 38963323 | PubTator, text mining | PubMed |
| Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta. | J Pediatr Endocrinol Metab | 2024 | 38953412 | PubTator, text mining | PubMed |
| Overexpression of heat shock protein 47 is associated with increased proliferation and metastasis in gastric cancer. | Genomics Inform | 2024 | 38907287 | PubTator, text mining | PubMed |
| Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases. | Genes Immun | 2024 | 38811682 | PubTator, text mining | PubMed |
| Radiofrequency Treatment Attenuates Age-Related Changes in Dermal-Epidermal Junctions of Animal Skin. | Int J Mol Sci | 2024 | 38791217 | PubTator, text mining | PubMed |
| SERPINH1 promoted the proliferation and metastasis of colorectal cancer by activating PI3K/Akt/mTOR signaling pathway. | World J Gastrointest Oncol | 2024 | 38764814 | PubTator, text mining | PubMed |
| Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity. | Cell Rep Med | 2024 | 38744278 | PubTator, text mining | PubMed |
| Levels of Small Extracellular Vesicles Containing hERG-1 and Hsp47 as Potential Biomarkers for Cardiovascular Diseases. | Int J Mol Sci | 2024 | 38732154 | PubTator, text mining | PubMed |
| Targeting HSP47 for cancer treatment. | Anticancer Drugs | 2024 | 38718070 | PubTator, text mining | PubMed |
| Comprehensive analysis of lncRNA-miRNA-mRNA ceRNA network in ischemic stroke. | Heliyon | 2024 | 38698974 | PubTator, text mining | PubMed |
| Platelet-rich fibrin as an autologous biomaterial for bone regeneration: mechanisms, applications, optimization. | Front Bioeng Biotechnol | 2024 | 38689760 | PubTator, text mining | PubMed |
| Insights into the Mechanism of Action of the Degraded Limonoid Prieurianin. | Int J Mol Sci | 2024 | 38612409 | PubTator, text mining | PubMed |
| Exome sequencing identified mutations in the WNT1 and COL1A2 genes in osteogenesis imperfecta cases. | Mol Biol Rep | 2024 | 38536562 | PubTator, text mining | PubMed |
| HSP47 Increases the Expression of Type I Collagen in Fibroblasts through IRE1α Activation, XBP1 Splicing, and Nuclear Translocation of β-Catenin. | Cells | 2024 | 38534372 | PubTator, text mining | PubMed |
| Integrative analysis of bulk RNA-seq and scRNA-seq data indicates the prognostic and immunologic values of SERPINH1 in glioma. | Environ Toxicol | 2024 | 38506564 | PubTator, text mining | PubMed |
| Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteins. | J Genet Eng Biotechnol | 2024 | 38494264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=9